KSE (KSE) Fair Value & Analysis
Consumer Non-Cyclicals · IN · Market cap ₹5.8B
Fair value as of: Jul 5, 2026
From 24 valuation models · updated today
Share price −4.6% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹171.59 – ₹271.48 · fair‑value band ₹233.08 – ₹557.85 · the ₹182.20 price screens below the ₹366.43 fair value. As of Jul 5, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
KSE (KSE) currently trades at ₹182.20, while our model-based Fair Value estimate is ₹366.43 — implying the stock looks roughly 101.1% undervalued today. We read business quality at 56/100 (solid quality), in the Consumer Non-Cyclicals sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, KSE generated revenue of ₹16.8B at a net margin of 5.0%. Revenue grew 4.3% year over year. It earns a return on equity of 26.0%. Net debt stands at ₹76.7M. Fundamentals as of Jul 5, 2026
Our scenario range runs from ₹233.08 (bear case) to ₹557.85 (bull case); at ₹182.20, the current price sits below that range. The share trades about 35% below its 52-week high and 5% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Non-Cyclicals peers we cover trades at 36% fair-value upside — at 101%, KSE screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
KSE reported revenue of ₹16.8B in FY2025 versus ₹16.7B in FY2021, a compound +0.2%/yr. Reported net income was ₹840M in FY2025, compounding +89.1%/yr from FY2021.
Is KSE fairly valued? → Check now
Similar stocks
10 more Food & Tobacco stocks, each showing price versus our Fair Value estimate (as of Jul 5, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| FB FB | 49.00 PHP | 44.00 PHP | -10% |
| URC URC | 59.00 PHP | 45.32 PHP | -23% |
| MONDE MONDE | 6.99 PHP | 1.11 PHP | -84% |
| CNPF CNPF | 26.75 PHP | 56.29 PHP | +110% |
| DNL DNL | 3.70 PHP | 5.04 PHP | +36% |
| RFM RFM | 5.49 PHP | 10.59 PHP | +93% |
| AXLM AXLM | 2.57 PHP | 3.34 PHP | +30% |
| Helixmith Co 084990 | 4,075 KRW | 1,488 KRW | -63% |
| EASY BIO,Inc. 353810 | 6,250 KRW | 16,375 KRW | +162% |
| ANI ANI | 0.4800 PHP | 0.9200 PHP | +92% |
Explore undervalued stocks
Frequently asked questions
Is KSE (KSE) undervalued?
What is the fair value of KSE?
What is the quality score of KSE?
What is the revenue of KSE (KSE)?
What is the net profit margin of KSE?
Does KSE pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.